KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Other Operating Expenses (2020 - 2025)

Pacific Biosciences Of California has reported Other Operating Expenses over the past 7 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at -$1.9 million for Q4 2025, down 102.1% from a year ago — trailing twelve months through Dec 2025 was $347.8 million (up 85.14% YoY), and the annual figure for FY2025 was $347.8 million, up 85.14%.
  • Other Operating Expenses for Q4 2025 was -$1.9 million at Pacific Biosciences Of California, down from -$1.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for PACB hit a ceiling of $353.2 million in Q1 2025 and a floor of -$52.0 million in Q1 2021.
  • Median Other Operating Expenses over the past 5 years was $626000.0 (2024), compared with a mean of $28.6 million.
  • Peak annual rise in Other Operating Expenses hit 15984.29% in 2025, while the deepest fall reached 360.06% in 2025.
  • Pacific Biosciences Of California's Other Operating Expenses stood at -$52.0 million in 2021, then skyrocketed by 103.95% to $2.1 million in 2022, then soared by 70.46% to $3.5 million in 2023, then soared by 2501.68% to $91.1 million in 2024, then plummeted by 102.1% to -$1.9 million in 2025.
  • The last three reported values for Other Operating Expenses were -$1.9 million (Q4 2025), -$1.6 million (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.